Tharimmune Announces Positive Topline Data with TH104, its Lead Candidate ...
Tharimmune Announces Positive Topline Data with TH104, its Lead Candidate ...
Stay updated with breaking news from Lead Candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tharimmune Announces Positive Topline Data with TH104, its Lead Candidate ...
Lead Candidate KYN-5356, a First-In-Class Small Molecule KAT-II Inhibitor, Advancing Toward the Clinic for Cognitive Impairment Associated With Schizophrenia…
EQS-News: Heidelberg Pharma AG / Key word(s): Study Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phas...
EQS-News: Heidelberg Pharma AG / Key word: Study Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101...
/PRNewswire/ -- Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer...